title: Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile.
authors.forename: S W
authors.initials: SW
authors.lastname: Pawlowski
authors.forename: L
authors.initials: L
authors.lastname: Archbald-Pannone
authors.forename: R J
authors.initials: RJ
authors.lastname: Carman
authors.forename: C
authors.initials: C
authors.lastname: Alcantara-Warren
authors.forename: D
authors.initials: D
authors.lastname: Lyerly
authors.forename: C W
authors.initials: CW
authors.lastname: Genheimer
authors.forename: D N
authors.initials: DN
authors.lastname: Gerding
authors.forename: R L
authors.initials: RL
authors.lastname: Guerrant
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001372:Aza Compounds / Q000494:pharmacology*; D016360:Clostridioides difficile / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D003015:Clostridium Infections / Q000382:microbiology / Q000503:physiopathology; D024881:Drug Resistance, Bacterial; D005243:Feces / Q000737:chemistry* / Q000382:microbiology; D024841:Fluoroquinolones / Q000494:pharmacology*; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D007422:Intestines / Q000276:immunology / Q000382:microbiology / Q000503:physiopathology; D007781:Lactoferrin / Q000032:analysis / Q000378:metabolism*; D008826:Microbial Sensitivity Tests; D000077266:Moxifloxacin; D011804:Quinolines / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D007781:Lactoferrin; D000077266:Moxifloxacin